Interestingly, administration of the Abl inhibitor imatinib lessens the clinical symptoms of patients with pulmonary arterial hypertension [65, 66], suggesting a role for Abl in pulmonary arterial contraction. Here, ABL1 is linked to pulmonary arterial hypertension.